New allergy shot for teens enters early safety testing
NCT ID NCT07513857
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study tests a new injection called JYB1904 in 12 teenagers aged 12-17 with allergies like hay fever, asthma, or food allergies. The main goal is to see if the drug is safe and how the body processes it. Participants will be closely monitored for side effects and drug levels in the blood.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALLERGIC DISEASES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can Early-Life factors steer preterm and term infant health?
- Probiotic cocktail may shield Antibiotic-Exposed infants from allergies
- Pregnancy diet study tracks moms and kids for five years
- EATING YOUR WAY TO CLEARER SKIN? NEW STUDY TESTS DIET FOR ECZEMA
- Massive study tracks 2500 kids from womb to uncover allergy roots
- New hope for chronic hives? experimental drug lesigercept enters Mid-Stage trial